Angie Schinkel

Angie Schinkel has a strong background in clinical operations, with progressive roles in various pharmaceutical companies. Angie'sexperience includes positions such as Vice President, Clinical Operations at Poseida Therapeutics, Inc., Executive Director at Retrophin, and Director at Halozyme Therapeutics, Inc. Angie has also worked as a Clinical Operations Management Consultant and held leadership positions at Spectrum Pharmaceuticals and Amylin Pharmaceuticals. Angie began their career at CroMedica and Quintiles.

Angie Schinkel attended UC San Diego from 1984 to 1988, where they obtained a Bachelor's degree in Psychology. Angie furthered their education at Alliant International University-San Diego Campus from 1990 to 1994, earning a Master's degree in Organizational Psychology.